These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 14705558)

  • 1. A model for economic analysis.
    Murray ME; Brennan PF; Moore SM
    Nurs Econ; 2003; 21(6):280-7, 259. PubMed ID: 14705558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating production costs in the economic evaluation of health-care programs.
    Herrero C; Moreno-Ternero JD
    Health Econ; 2009 Jan; 18(1):21-35. PubMed ID: 18264993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the triple P-Positive Parenting Program provide value for money?
    Mihalopoulos C; Sanders MR; Turner KM; Murphy-Brennan M; Carter R
    Aust N Z J Psychiatry; 2007 Mar; 41(3):239-46. PubMed ID: 17464705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation for ophthalmologists.
    Kuper H; Jofre-Bonet M; Gilbert C
    Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for economic analysis in research on child maltreatment.
    Corso PS; Lutzker JR
    Child Abuse Negl; 2006 Jul; 30(7):727-38. PubMed ID: 16854463
    [No Abstract]   [Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [For and against: the Integrated Plan of Treatment and Rehabilitation (IBRP) and the Conference on the Help Plan (HPK)].
    Vorbach EU
    Psychiatr Prax; 2006 Jan; 33(1):3-5. PubMed ID: 16389576
    [No Abstract]   [Full Text] [Related]  

  • 9. [Models of economic evaluation of health and safety interventions at workplace].
    Rydlewska-Liszkowska I
    Med Pr; 2005; 56(5):411-8. PubMed ID: 16483013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal health models in Latin America: development of national programs of renal health.
    Depine S; Calderón RB
    Ren Fail; 2006; 28(8):649-64. PubMed ID: 17162423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic valuation through cost-benefit analysis--possibilities and limitations.
    Hansjürgens B
    Toxicology; 2004 Dec; 205(3):241-52. PubMed ID: 15464633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Implementing integrated health care--current state and progress].
    Stamm J
    Z Kardiol; 2005; 94 Suppl 4():IV/4-6. PubMed ID: 16416063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of vector control techniques: an economic approach].
    Audibert M
    Med Trop (Mars); 2009 Apr; 69(2):185-93. PubMed ID: 19545044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative cost-benefit evaluation of complex, emergent programs.
    Rogers PJ; Stevens K; Boymal J
    Eval Program Plann; 2009 Feb; 32(1):83-90. PubMed ID: 19007990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of innovative technologies in health care should include a short-run perspective.
    Adang EM
    Eur J Health Econ; 2008 Nov; 9(4):381-4. PubMed ID: 18188622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality management in the ophthalmologist's practice].
    Heinz P
    Ophthalmologe; 2004 Oct; 101(10):982-92. PubMed ID: 15338184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of strategies to disseminate and implement clinical guidelines for the management of impacted and unerupted third molars in primary dental care, a cluster randomised controlled trial.
    Bahrami M; Deery C; Clarkson JE; Pitts NB; Johnston M; Ricketts I; MacLennan G; Nugent ZJ; Tilley C; Bonetti D; Ramsay C
    Br Dent J; 2004 Dec; 197(11):691-6; discussion 688. PubMed ID: 15592551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.